2 results
Approved WMOCompleted
The study aims to limit the use of anthracyclines and to reduce the dose of ATRA. Another aim is to stratify treatment by risk group: standard risk - WBC <10 x 109/l : high risk - WBC >=10 x 109/l. Furthermore this study aims to…
Approved WMOPending
Primary Objective: To assess the safety of long-term administration of KVD900 in adolescent and adult patients with HAE type I or II.Secondary Objectives: • To assess the long-term efficacy of KVD900 in the treatment of attacks in adolescent and…